CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a U.S. National Stage Application pursuant to 35 U.S.C. .sctn.371 of International Patent Application PCT/EP2013/071445, filed on Oct. 14, 2013, and published as WO 2014/060366 on Apr. 24, 2014, which claims priority to European Patent
II. INTRODUCTION
Cancer is a leading cause of death in the industrialized world and despite years of research, many types of cancer lack an effective therapeutic treatment. Although chemotherapy induces remission in the majority of adult patients with acute myeloid leukemia (AML), only a small
BACKGROUND OF THE INVENTION
This invention relates to a method of inhibiting production of TNF (tumor necrosis factor) in a mammal in need thereof which method comprises administering to said mammal an effective amount of a compound of the formula (I) (shown below) or a pharmaceutically acceptable
BACKGROUND OF THE INVENTION
This invention relates to catechol diethers containing a long lipophilic sidechain which are selective inhibitors of phosphodiesterase (PDE) type IV or the production of tumor necrosis factor (TNF) and as such are useful in the treatment of asthma, arthritis, bronchitis,
FIELD OF THE INVENTION
The present invention relates generally to sulfone phosphonate compounds and their use in organic synthesis and, more particularly, to disulfone bis-phosphonates and their preparation and use as reagents in the synthesis of biologically relevant disulfones.
BACKGROUND OF THE
BACKGROUND AND SUMMARY OF THE INVENTION
I. Field of the Invention
The present invention generally relates to a therapeutic composition. More particularly, the present invention relates to a pharmaceutical, nutraceutical, or nutratherapeutical formulation that includes antioxidants. The formulation
BACKGROUND AND SUMMARY OF THE INVENTION
I. Field of the Invention
The present invention generally relates to a therapeutic composition. More particularly, the present invention relates to a pharmaceutical, nutraceutical, or nutratherapeutical formulation that includes antioxidants. The formulation
BACKGROUND AND SUMMARY OF THE INVENTION
I. Field of the Invention
The present invention generally relates to a therapeutic composition. More particularly, the present invention relates to a pharmaceutical, nutraceutical, or nutratherapeutical formulation that includes antioxidants. The formulation
BACKGROUND AND SUMMARY OF THE INVENTION
I. Field of the Invention
The present invention generally relates to therapeutic compositions and formulations with catechol. More particularly, the present invention relates to an oral medicament, a dietary supplement, a nutritional supplement, a food
The most complete medicinal herbs database backed by science
Works in 55 languages
Herbal cures backed by science
Herbs recognition by image
Interactive GPS map - tag herbs on location (coming soon)
Read scientific publications related to your search
Search medicinal herbs by their effects
Organize your interests and stay up do date with the news research, clinical trials and patents
Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against. *All information is based on published scientific research